Sarshan R. Pather

Sarshan R. Pather

Auto-generated profile, based on publicly available information

Sarshan R. Pather

Medical Scientist Training Program, Perelman School of Medicine, University of Pennsylvania, Philadelphia

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Development
Verified
Journal Article
Open access
PDF file
LZLudovic Zimmerlin
Ludovic Zimmerlin
TPTea Soon Park
Tea Soon Park
JHJeffrey S. Huo
Jeffrey S. Huo
KVKaran Verma
Karan Verma
SPSarshan R. Pather
Sarshan R. Pather
EZElias T. Zambidis
Elias T. Zambidis
The derivation and maintenance of human pluripotent stem cells (hPSCs) in stable naïve pluripotent states has a wide impact in human developmental biology. However, hPSCs are unstable in classical naïve mouse embryonic stem cell (ESC) WNT and MEK/ERK signal inhibition (2i) culture. We show that a broad repertoire of conventional hESC and transgene-independent human induced pluripotent stem cell (hiPSC) lines could be reverted to stable human preimplantation inner cell mass (ICM)-like naïve states with only WNT, MEK/ERK, and tankyrase inhibition (LIF-3i). LIF-3i-reverted hPSCs retained normal karyotypes and genomic imprints, and attained defining mouse ESC-like functional features, including high clonal self-renewal, independence from MEK/ERK signaling, dependence on JAK/STAT3 and BMP4 signaling, and naïve-specific transcriptional and epigenetic configurations. Tankyrase inhibition promoted a stable acquisition of a human preimplantation ICM-like ground state via modulation of WNT signaling, and was most efficacious in efficiently reprogrammed conventional hiPSCs. Importantly, naïve reversion of a broad repertoire of conventional hiPSCs reduced lineage-primed gene expression and significantly improved their multilineage differentiation capacities. Stable naïve hPSCs with reduced genetic variability and improved functional pluripotency will have great utility in regenerative medicine and human disease modeling.

1 March 2019 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
GCGregory M. Chen
Gregory M. Chen
SPSarshan R. Pather
Sarshan R. Pather
HDHorace M. DeLisser
Horace M. DeLisser
The culture of clinical investigation has undergone dramatic changes in the past 40 years. The 1970s marked the high-profile termination of the Tuskegee Syphilis Study and subsequent drafting of the National Research Act and Belmont Report, which set new ethical and legal frameworks for human research.1,2 Central to these documents was an understanding of the dual view that physician-scientists must take to recognize patients as research participants and complex individuals. More recently, the rise of evidence-based medicine has encouraged higher standards of scientific rigor in clinical studies, favoring evidence from large randomized clinical trials over case reports and clinical experience. Evidence-based medicine has offered a cultural paradigm shift in not only the experimental design of medical research, but the central thought processes regarding patients, clinical decision making, and the origin of medical knowledge.3,4 Concurrent with these major movements, the physician-patient relationship has changed, emphasizing the importance of communication and favoring patient autonomy over paternalism.5-9